Connect
Using Cell-Based Therapies to Shape the Future of HLHS
Here at the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, we are working on new ways to delay and even prevent heart transplants for people with congenital heart defects. In order to do that, we are studying cell-based treatments, human genetics and advanced imaging techniques along with creating the world's largest biorepository for HLHS patients and families. 
In the video below, we explain in detail the exciting promise stem cells hold for the future of HLHS.
If you have any questions or are interested in our program, email us at HLHS@mayo.edu.
The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science, to diagnostic imaging to regenerative therapies.
Like
Helpful
HugInterested in more newsfeed posts like this? Go to the HLHS blog.
Connect